On NSBB n = 65 | Not on NSBB n = 105 | P value | |
---|---|---|---|
Age, years | 58 (52–64) | 59 (53–63) | NS |
BMI | 28 (25–35) | 29 (25–35) | NS |
Male gender | 43 (66%) | 64 (64%) | NS |
Diabetes mellitus | 21 (32%) | 33 (32%) | NS |
Hypertension | 28 (43%) | 52 (50%) | NS |
Chronic kidney disease | 16 (25%) | 11 (11%) | .02 |
Heart rate beats/min | 66 (60–73) | 78 (70–88) | <.001 |
Mean arterial pressure, mmHg | 82 (76–93) | 86 (78–93) | NS |
Race | |||
Caucasian | 57 (88%) | 91 (87%) | NS |
Black | 3 (5%) | 7 (7%) | |
Hispanic | 4 (6%) | 5 (5%) | |
Other | 1 (1%) | 2 (2%) | |
Cirrhosis Etiology | |||
Hepatitis C | 27 (42%) | 57 (54%) | NS |
Alcohol | 23 (34%) | 31 (30%) | NS |
NASH | 20 (30%) | 22 (21%) | NS |
Child Pugh Score | 10 (9–11) | 9 (7–10) | .001 |
Child Pugh class | |||
A | 3 (5%) | 16 (15%) | .01 |
B | 24 (37%) | 50 (48%) | |
C | 38 (58%) | 39 (38%) | |
MELD | 16 (14–19) | 14 (10–19) | 0.03 |
INR | 1.5 (1.3–1.7) | 1.3 (1.2–1.6) | .04 |
Bilirubin mg/dL | 2.7 (2–3.7) | 1.9 (1.3–3.5) | .04 |
Creatinine mg/dL | 1.1 (0.8–1.4) | 0.9 (0.7–1.2) | .1 |
Albumin g/dL | 2.9 (2.5–3.1) | 3 (2.5–3.4) | NS |
Sodium | 135 (132–137) | 135 (131–138) | NS |
Esophageal varices | |||
None or small | 24 (37%) | 70 (71%) | <.001 |
Non-bleeding large | 21 (32%) | 19 (19%) | |
Prior bleeding | 20 (31%) | 13 (13%) | |
Gastric varices | |||
None or small | 61 (94%) | 100 (98%) | NS |
Non-bleeding large | 2 (3%) | None | |
Prior bleeding | 2 (3%) | 2 (2%) | |
Ascites | |||
None | 12 (18%) | 30 (30%) | NS |
Controlled | 35 (55%) | 53 (51%) | |
Refractory | 18 (27%) | 21 (20%) | |
Hepatic encephalopathy | |||
None | 18 (28%) | 41 (40%) | NS |
Controlled | 32 (48%) | 48 (47%) | |
Refractory | 15 (24%) | 14 (13%) | |
Transjugular Intrahepatic Portosystemic shunt | 5 (8%) | 13 (13%) | NS |
Cirrhosis complications | |||
Spontaneous bacterial peritonitis | 2 (3%) | 3 (3%) | NS |
Hepatorenal syndrome | 2 (3%) | 3 (3%) | NS |
Hepatopulmonary syndrome | None | 2 (2%) | NS |
Portopulmonary hypertension | 2 (3%) | 5 (5%) | NS |
Hepatocellular carcinoma | 10 (15%) | 26 (26%) | NS |
Acute kidney injury associated with hospitalization prior to liver transplant evaluation | 7 (11%) | 13 (13%) | NS |
NSBB indication | |||
Large or previously bleeding varices | 42 (65%) | 34 (32%) | <.001 |
NSBB contraindication (refractory ascites or spontaneous bacterial peritonitis) | 20 (31%) | 24 (23%) | NS |